全球 DNA 诊断市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势和预测

全球 DNA 诊断市场需求预计将从 2022 年的 112.1 亿美元增至 2030 年的近 169.3 亿美元，2023-2030 年研究期间复合CAGR为 5.29%。

DNA 诊断，也称为基因测试或DNA 测试，是一套实验室技术和程序，用于分析个体的DNA（脱氧核糖核酸），以获取有关其基因组成、遗传倾向、血统和潜在遗传疾病或状况的讯息。它提供了有关个人基因组成的宝贵见解，帮助医疗保健专业人员就疾病诊断、风险评估和治疗做出明智的决定。

市场动态：

基因组研究的进步加深了对遗传与疾病和病症之间联繫的理解，刺激了对 DNA 诊断的需求，以评估遗传倾向和个人化医疗保健。人们对基因检测对健康风险评估、血统追踪和个人化医疗的潜在益处的认识不断提高，大大增加了需求。精准医学的概念是根据个别基因图谱客製化医疗干预措施，在很大程度上依赖 DNA 诊断。此外，癌症盛行率的上升以及遗传讯息在癌症治疗决策中的整合推动了市场的发展，基因检测被用来识别突变并指导治疗。药物基因组学、产前和新生儿筛检、直接面向消费者的测试、监管支援和技术进步都促进了市场的成长。此外，生物技术和製药公司的标靶治疗、个人化医疗保健以及研究投资正在扩大 DNA 诊断的效用。随着人口老化和个人化医疗保健趋势的持续存在，DNA 诊断市场预计将继续发展，提供更广泛的测试和应用。然而，围绕基因资料的伦理和隐私问题仍将是市场发展的重要面向。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球 DNA 诊断市场的各个细分市场进行了包容性评估。 DNA 诊断产业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲 DNA 诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 DNA诊断市场的主要参与者包括GE Healthcare、Abbott、Beckman Coulter Inc.、Bio-Rad Laboratories, Inc.、Thermo Fisher Scientific Inc.、Illumina Inc.、Cepheid、Hologic Inc.、Siemens Healthcare GmbH、F. Hoffmann - La Roche、QIAGEN、Agilent Technologies Inc。本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布，以及其他进展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：DNA 诊断 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按技术分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球 DNA 诊断市场分析：依技术分类

• 依技术概述
• 历史和预测数据
• 依技术分析
• 基于微阵列的诊断
• 基于 PCR 的诊断
• 原位杂交诊断
• NGS DNA诊断

第 6 章：全球 DNA 诊断市场分析：依应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 癌症遗传学测试
• 传染病DNA检测（HBV诊断、HCV诊断、HIV诊断、结核病诊断、CT/NG诊断、HPV诊断、MRSA诊断、其他）
• 新生儿基因筛检
• 植入前和生殖诊断
• 非传染性疾病 DNA 检测（心血管疾病、中枢神经系统和三七总皂苷相关、骨骼、结缔、外胚层和真皮 DNA 检测、肺、肾、肝臟和 GT 相关、感觉疾病）
• 产前 DNA 带因者筛检
• 药物基因体学/药物代谢
• 血液学与免疫学/身分诊断与法医学
• 其他的

第 7 章：全球 DNA 诊断市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 8 章：DNA 诊断公司的竞争格局

• DNA诊断市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 9 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• GE Healthcare
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Abbott
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Beckman Coulter Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bio-Rad Laboratories Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Thermo Fisher Scientific Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Illumina Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Cepheid
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Hologic Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Siemens Healthcare GmbH
• 公司简介
• 公司收入
• 产品
• 最近的发展
• F. Hoffmann-La Roche
• 公司简介
• 公司收入
• 产品
• 最近的发展
• QIAGEN
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Agilent Technologies Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for DNA Diagnostics Market is presumed to reach the market size of nearly USD 16.93 BN by 2030 from USD 11.21 BN in 2022 with a CAGR of 5.29% under the study period 2023 - 2030.

DNA diagnostics, also known as genetic testing or DNA testing, is a set of laboratory techniques and procedures used to analyze an individual's DNA (deoxyribonucleic acid) to gain information about their genetic makeup, genetic predispositions, ancestry, and potential genetic disorders or conditions. It provides valuable insights into an individual's genetic composition, helping healthcare professionals make informed decisions about disease diagnosis, risk assessment, and treatment.

MARKET DYNAMICS:

Advancements in genomic research have deepened the understanding of genetic links to diseases and conditions, spurring the demand for DNA diagnostics to assess genetic predispositions and personalize healthcare. This surge in awareness among individuals about genetic testing's potential benefits for health risk assessment, ancestry tracing, and personalized medicine has significantly boosted demand. The concept of precision medicine, which customizes healthcare interventions based on individual genetic profiles, relies heavily on DNA diagnostics. Additionally, the rising prevalence of cancer and the integration of genetic information in cancer treatment decisions have fueled the market, with genetic testing being used to identify mutations and guide therapy. Pharmacogenomics, prenatal and newborn screening, direct-to-consumer testing, regulatory support, and advancements in technology have all contributed to the market's growth. Furthermore, targeted therapies, healthcare personalization, and research investments by biotech and pharmaceutical companies are expanding the utility of DNA diagnostics. As the aging population and the trend toward personalized healthcare persist, the DNA diagnostics market is expected to continue evolving, offering a wider range of tests and applications. However, ethical and privacy concerns surrounding genetic data will remain a significant aspect of the market's development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dna diagnostics. The growth and trends of dna diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the dna diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

• Microarrays-Based Diagnostics
• PCR-Based Diagnostics
• In-Situ Hybridization Diagnostics
• NGS DNA Diagnosis

By Application

• Cancer Genetics Tests
• Infectious Diseases Dna Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others)
• Newborn Genetic Screening
• Preimplantation & Reproductive Diagnosis
• Non-Infectious Diseases Dna Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases)
• Prenatal DNA Carrier Screening
• Pharmacogenomics/Drug Metabolism
• Hematology & Immunology/Identity Diagnostics & Forensics
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the DNA Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the DNA Diagnostics market include GE Healthcare, Abbott, Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Illumina Inc., Cepheid, Hologic Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche, QIAGEN, Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . DNA DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technology
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

• 5.1 Overview by Technology
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Technology
• 5.4 Microarrays-based Diagnostics Historic and Forecast Sales by Regions
• 5.5 PCR-based Diagnostics Historic and Forecast Sales by Regions
• 5.6 In-situ Hybridization Diagnostics Historic and Forecast Sales by Regions
• 5.7 NGS DNA Diagnosis Historic and Forecast Sales by Regions

6 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Cancer Genetics Tests Historic and Forecast Sales by Regions
• 6.5 Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Historic and Forecast Sales by Regions
• 6.6 Newborn Genetic Screening Historic and Forecast Sales by Regions
• 6.7 Preimplantation & Reproductive Diagnosis Historic and Forecast Sales by Regions
• 6.8 Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Historic and Forecast Sales by Regions
• 6.9 Prenatal DNA Carrier Screening Historic and Forecast Sales by Regions
• 6.10. Pharmacogenomics/Drug Metabolism Historic and Forecast Sales by Regions
• 6.11 Hematology & Immunology/Identity Diagnostics & Forensics Historic and Forecast Sales by Regions
• 6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DNA DIAGNOSTICS COMPANIES

• 8.1. Dna Diagnostics Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF DNA DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. GE Healthcare
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Abbott
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Beckman Coulter Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Bio-Rad Laboratories Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Thermo Fisher Scientific Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Illumina Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Cepheid
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Hologic Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. Siemens Healthcare GmbH
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. F. Hoffmann-La Roche
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments
• 9.13. QIAGEN
  • 9.13.1. Company Overview
  • 9.13.2. Company Revenue
  • 9.13.3. Products
  • 9.13.4. Recent Developments
• 9.14. Agilent Technologies Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Company Revenue
  • 9.14.3. Products
  • 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Technology (USD MN)
• Microarrays-based Diagnostics Market Sales by Geography (USD MN)
• PCR-based Diagnostics Market Sales by Geography (USD MN)
• In-situ Hybridization Diagnostics Market Sales by Geography (USD MN)
• NGS DNA Diagnosis Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Cancer Genetics Tests Market Sales by Geography (USD MN)
• Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Market Sales by Geography (USD MN)
• Newborn Genetic Screening Market Sales by Geography (USD MN)
• Preimplantation & Reproductive Diagnosis Market Sales by Geography (USD MN)
• Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Market Sales by Geography (USD MN)
• Prenatal DNA Carrier Screening Market Sales by Geography (USD MN)
• Pharmacogenomics/Drug Metabolism Market Sales by Geography (USD MN)
• Hematology & Immunology/Identity Diagnostics & Forensics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Dna Diagnostics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Dna Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Dna Diagnostics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Technology (USD MN)
• Microarrays-based Diagnostics Market Sales by Geography (USD MN)
• PCR-based Diagnostics Market Sales by Geography (USD MN)
• In-situ Hybridization Diagnostics Market Sales by Geography (USD MN)
• NGS DNA Diagnosis Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Cancer Genetics Tests Market Sales by Geography (USD MN)
• Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Market Sales by Geography (USD MN)
• Newborn Genetic Screening Market Sales by Geography (USD MN)
• Preimplantation & Reproductive Diagnosis Market Sales by Geography (USD MN)
• Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Market Sales by Geography (USD MN)
• Prenatal DNA Carrier Screening Market Sales by Geography (USD MN)
• Pharmacogenomics/Drug Metabolism Market Sales by Geography (USD MN)
• Hematology & Immunology/Identity Diagnostics & Forensics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.